Difference between revisions of "Miinalainen IJ"
From Bioblast
Marte Verena (talk | contribs) |
Beno Marija (talk | contribs) |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
|country=Finland | |country=Finland | ||
|weblink=[www. oulu.fi/biocenter/em] | |weblink=[http://www.oulu.fi/biocenter/em Biocenter Oulo] | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | |||
::::* [[IOC47|IOC47 Schroecken AT]] |
Latest revision as of 16:30, 12 February 2018
Name | Miinalainen Ilkka, Ph.D. |
---|---|
Institution | Biocenter Oulu Electron Microscopy Core Facility
University of Oulu |
Address | Aapistie 5A, 90220 |
City | Oulu |
State/Province | |
Country | Finland |
[email protected] | |
Weblink | Biocenter Oulo |
O2k-Network Lab | IE Dublin Miinalainen I |
Labels:
Publications
Published | Reference | |
---|---|---|
Raesaenen 2016 Proc Natl Acad Sci U S A | 2016 | Räsänen M, Degerman J, Nissinen TA, Miinalainen I, Kerkelä R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivelä R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49. |